Study S001775

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study Evaluating the Efficacy and Safety of HRS-7535 in Subjects With Heart Failure, Mild Reduction/Preservation of Ejection Fraction, and Obesity

ClinicalTrials.gov record

Registration

Registration: NCT06820099
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: QUADRUPLE
Status: RECRUITING
Enrollment: 225
Start: 2025-04-10
Primary completion: 2026-12
Lead sponsor: Shandong Suncadia Medicine Co., Ltd.
Conditions: Adults With Heart Failure, Mild Decrease in Ejection Fraction/Preserved Ejection Fraction, and Obesity
Interventions: DRUG:HRS-7535 tablet; DRUG:HRS-7535 tablet placebo
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

The percentage change from baseline in body weight. [At week 36.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.